13F HOLDINGS REPORT
Eagle Health Investments LP
Quarter ended Q3 2025 · Filed November 7, 2025 · Accession 0001172661-25-004632
Total Value
$380.9M
Positions
23
Other Managers
0
Confidential Omitted
No
Holdings (23)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARGENX SE | ARGX | 77,430 | $57.1M | 14.99% |
| 2 | INSMED INC | INSM | 271,600 | $39.1M | 10.27% |
| 3 | NATERA INC | NTRA | 203,664 | $32.8M | 8.61% |
| 4 | ICON PLC | ICLR | 182,590 | $32.0M | 8.39% |
| 5 | ILLUMINA INC | ILMN | 322,261 | $30.6M | 8.03% |
| 6 | NEUROCRINE BIOSCIENCES INC | NBIX | 162,800 | $22.9M | 6.00% |
| 7 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 697,000 | $21.0M | 5.50% |
| 8 | BIOMARIN PHARMACEUTICAL INC | BMRN | 366,812 | $19.9M | 5.22% |
| 9 | GUARDANT HEALTH INC | GH | 284,100 | $17.8M | 4.66% |
| 10 | EXACT SCIENCES CORP | 30063P105 | 270,950 | $14.8M | 3.89% |
| 11 | SCHOLAR ROCK HLDG CORP | SRRK | 363,300 | $13.5M | 3.55% |
| 12 | BRIDGEBIO PHARMA INC | BBIO | 259,300 | $13.5M | 3.54% |
| 13 | PROCEPT BIOROBOTICS CORP | PRCT | 308,434 | $11.0M | 2.89% |
| 14 | ALNYLAM PHARMACEUTICALS INC | ALNY | 23,686 | $10.8M | 2.84% |
| 15 | AKERO THERAPEUTICS INC | 00973Y108 | 226,400 | $10.7M | 2.82% |
| 16 | AGIOS PHARMACEUTICALS INC | AGIO | 246,230 | $9.9M | 2.59% |
| 17 | FORTREA HLDGS INC | FTRE | 988,772 | $8.3M | 2.19% |
| 18 | COMPASS PATHWAYS PLC | CMPS | 935,450 | $5.4M | 1.41% |
| 19 | CENTESSA PHARMACEUTICALS PLC | CNTA | 103,100 | $2.5M | 0.66% |
| 20 | ALKERMES PLC | ALKS | 81,800 | $2.5M | 0.64% |
| 21 | INTUITIVE SURGICAL INC | ISRG | 4,390 | $2.0M | 0.52% |
| 22 | IMMUNOCORE HLDGS PLC | IMCR | 46,300 | $1.7M | 0.44% |
| 23 | VIR BIOTECHNOLOGY INC | VIR | 240,500 | $1.4M | 0.36% |